Key result
Watchman achieves successful LAA closure in an 82-year-old contraindicated for oral anticoagulation.
Why the study?
Left atrial appendage closure is a therapeutic approach to prevent thromboembolism in atrial fibrillation patients with contraindications to anticoagulants.
Case Report (n=1)
No
Supports Watchman LAA closure feasibility in high-bleeding-risk AF; leaves open need for prospective outcome data before wider adoption.
We herein present the first left atrial appendage (LAA) percutaneous closure procedure performed in our Institution with use of the Watchman device in an 82-year old woman with atrial fibrillation, unable to continue receiving anticoagulation therapy due to bleeding complications. A propos with this case, we discuss the data related to this therapeutic approach geared to prevent thromboembolism in patients with atrial fibrillation and contraindications to treatment with anticoagulants.
No takes yet. Share an insight, caveat, or question.
Toutouzas et al. (2014) conducted a case report in Atrial fibrillation (n=1). Watchman device was evaluated on Procedural success and complete occlusion of the left atrial appendage. Percutaneous left atrial appendage closure using the Watchman device was successfully performed without complications in an 82-year-old woman with atrial fibrillation and a contraindication to oral anticoagulants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: